)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Lumito
Lumito (LUMITO) investor relations material
Lumito Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary7 May, 2026
Executive summary
Achieved first commercial revenues with net sales of 78 TSEK in Q1 2026, marking transition from development to commercialization of SCIZYS platform.
Strategic partnerships and pilot projects initiated with leading academic and industry players, including Atlas Antibodies, Offspring Biosciences, OracleBio, and Tethis.
Patent protection expanded with approval in India, complementing existing coverage in Europe and the US.
Structural changes implemented, including share consolidation and capital structure adjustments, to support future growth.
First revenues from CRO partnerships realized post-period, validating the business model.
Financial highlights
Net sales reached 78 TSEK in Q1 2026, compared to 0 TSEK in Q1 2025.
Net loss after tax improved to -10,495 TSEK from -11,803 TSEK year-over-year.
Operating loss was -10,226 TSEK, compared to -11,374 TSEK in Q1 2025.
Cash flow from operations was -6,732 TSEK, nearly unchanged from -6,784 TSEK last year.
Cash and cash equivalents at period end were 8,990 TSEK, down from 14,711 TSEK a year earlier.
Outlook and guidance
Focus remains on converting pilot projects and partnerships into long-term commercial contracts.
Continued expansion of the SCIZYS ecosystem and commercialization efforts expected to drive growth.
Activities in Q1 2026 have laid the foundation for broader market acceptance and scaling.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lumito
- SCIZYS market launch advances with strategic partnerships, improved cost control, and strong equity.LUMITO
Q4 202520 Feb 2026 - Nanoparticle-based tissue diagnostics platform targets scalable growth via CRO partnerships.LUMITOLife Science Summit 20253 Feb 2026
- SCIZYS commercialization advanced with new partnerships and improved financial stability.LUMITOQ3 202527 Nov 2025
- Net loss increased and cash reserves fell as commercialization efforts for SCIZYS intensified.LUMITOQ2 202511 Aug 2025
- CE-marking of SCIZYS marks Lumito's commercial launch, with financing and partnerships in place.LUMITOQ3 202413 Jun 2025
- SCIZYS CE marking propels Lumito into commercialization amid growing digital pathology demand.LUMITOQ2 202413 Jun 2025
- Lumito reported a wider Q1 loss amid strategic shifts and ongoing commercialization efforts.LUMITOQ1 20256 Jun 2025
- Net loss widened as Lumito launched Scizys and secured new financing for growth.LUMITOQ4 20245 Jun 2025
Next Lumito earnings date
Q2 202620 Aug, 2026
Lumito
Next Lumito earnings date
Q2 202620 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage